Myriad RBM Expands Its Biomarker Panel for Oncology
Cancer is a remarkably complex disease that can affect nearly every system and pathway in the body. A new panel of biomarkers from Myriad RBM (Oncolog...
Do Biomarkers for Traumatic Brain Injury Overlap with Other Neurodegenerative Disorders?
A Swedish group of researchers has published a study taking a look at CSF biomarkers following repetitive head trauma. After collecting samples from O...
Major Depression and Alzheimer’s Disease: A common link?
The association between depression and AD is not new but a new article published in The American Journal of Psychiatry offers a look into one possible...
Breast Cancer Protein Linked to Metastasis
A new study published in the Journal of American Pathology underscores the importance of understanding the role that a biomarker target plays in both...
Blood-based or CSF-based?
Do you think drug development groups and clinical researchers would rather have a biomarker discovery tool for neurodegenerative disease that is blood...
How soon do Alzheimer’s biomarkers start taking their toll?
Currently, hopes of preventing the worst of the decline seen with Alzheimer's disease lie in the early detection or identifying those who are predispo...